About Athersys, Inc.

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.33$ per share.

The book value per share is 0.41$

Athersys, Inc. website

Create a solid portfolio with ATHX

Add ATHX to your portfolio and optimize it!


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- 100.00% -56M -807.50% -56M -0.33 - - 166M 0.41 -43M -1M -44M